Literature DB >> 29138482

Valgamicin C, a novel cyclic depsipeptide containing the unusual amino acid cleonine, and related valgamicins A, T and V produced by Amycolatopsis sp. ML1-hF4.

Hideki Hashizume1, Kiyoko Iijima1, Kazuma Yamashita1, Tomoyuki Kimura1, Shun-Ichi Wada1, Ryuichi Sawa1, Masayuki Igarashi1.   

Abstract

In the course of optimizing pargamicin A production in Amycolatopsis sp. ML1-hF4, we discovered novel cyclic depsipeptide compounds in the broth and designated them valgamicins A, C, T and V. The structures of these molecules were determined by spectroscopic studies, advanced Marfey's method and X-ray crystal structural analysis. Valgamicin C contains the extremely rare amino acid cleonine. To our knowledge, this is the first report of a cleonine-containing metabolite from a naturally isolated microorganism without any breeding or mutation treatment. None of the valgamicins showed potent antibacterial activity against either Gram-positive or -negative bacteria. Valgamicins A, C and T exhibited moderate cytotoxicity against human tumor cell lines.The Journal of Antibiotics advance online publication, 15 November 2017; doi:10.1038/ja.2017.135.

Entities:  

Year:  2017        PMID: 29138482     DOI: 10.1038/ja.2017.135

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

1.  Band-selective HSQC and HMBC experiments using excitation sculpting and PFGSE.

Authors:  C Gaillet; C Lequart; P Debeire; J M Nuzillard
Journal:  J Magn Reson       Date:  1999-08       Impact factor: 2.229

2.  Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.

Authors:  Hideki Hashizume; Hayamitsu Adachi; Masayuki Igarashi; Yoshio Nishimura; Yuzuru Akamatsu
Journal:  J Antibiot (Tokyo)       Date:  2010-03-26       Impact factor: 2.649

Review 3.  Natural Products as Sources of New Drugs from 1981 to 2014.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2016-02-07       Impact factor: 4.050

Review 4.  Antibiotics in the clinical pipeline at the end of 2015.

Authors:  Mark S Butler; Mark At Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

5.  FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  T Kino; H Hatanaka; M Hashimoto; M Nishiyama; T Goto; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

6.  The antibiotic YA-56 complex: isolation, purification and physicochemical properties of the main components.

Authors:  Y Ito; Y Oashi; S Kawabe; M Sakurazawa; T Ogawa
Journal:  J Antibiot (Tokyo)       Date:  1973-02       Impact factor: 2.649

7.  Chemistry of bleomycin. XXVII. Cleomycin, a new family of bleomycin-phleomycin group.

Authors:  H Umezawa; Y Muraoka; A Fujii; H Naganawa; T Takita
Journal:  J Antibiot (Tokyo)       Date:  1980-09       Impact factor: 2.649

8.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

9.  Bleomycin and other antitumor antibiotics of high molecular weight.

Authors:  H Umezawa
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

10.  Novel autophagy inducers lentztrehaloses A, B and C.

Authors:  Shun-ichi Wada; Yumiko Kubota; Ryuichi Sawa; Maya Umekita; Masaki Hatano; Shun-ichi Ohba; Chigusa Hayashi; Masayuki Igarashi; Akio Nomoto
Journal:  J Antibiot (Tokyo)       Date:  2015-03-11       Impact factor: 2.649

View more
  4 in total

Review 1.  The secondary metabolites of rare actinomycetes: chemistry and bioactivity.

Authors:  Ting Ding; Luo-Jie Yang; Wei-Dong Zhang; Yun-Heng Shen
Journal:  RSC Adv       Date:  2019-07-16       Impact factor: 4.036

2.  Integrating vectors for genetic studies in the rare Actinomycete Amycolatopsis marina.

Authors:  Hong Gao; Buvani Murugesan; Janina Hoßbach; Stephanie K Evans; W Marshall Stark; Margaret C M Smith
Journal:  BMC Biotechnol       Date:  2019-06-04       Impact factor: 2.563

Review 3.  Secondary Metabolites of the Genus Amycolatopsis: Structures, Bioactivities and Biosynthesis.

Authors:  Zhiqiang Song; Tangchang Xu; Junfei Wang; Yage Hou; Chuansheng Liu; Sisi Liu; Shaohua Wu
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

4.  Suertides A-C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3.

Authors:  Heather J Lacey; Rachel Chen; Daniel Vuong; Mark F Fisher; Ernest Lacey; Peter J Rutledge; Andrew M Piggott
Journal:  J Antibiot (Tokyo)       Date:  2022-07-26       Impact factor: 3.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.